ABBOTT LABORATORIES reported first-quarter financial results that exceeded Wall Street estimates, driven by the strength of its medical device division and its strategic expansion into the cancer diagnostics market.

Abbott beat Q1 estimates with $11.16 billion in revenue. Results were aided by medical device sales and the acquisition of cancer-test maker Exact Sciences.
ABBOTT LABORATORIES reported first-quarter financial results that exceeded Wall Street estimates, driven by the strength of its medical device division and its strategic expansion into the cancer diagnostics market.

Everything you use on the web — faster, and in your pocket.